Nowak, Richard J et al "Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study." Neurology (2021): 10.1212/WNL.0000000000013121. Web. 21 May. 2022.